A one-day event on 7th March 2008 at the Biopark Hertfordshire

 

Regulatory T cells continue to fascinate scientists as the phenotypic and functional characteristics of the different subsets emerges.  The latest focus from key researchers and commercial companies will be presented at this meeting and there will be opportunities throughout the day for researchers and commercial companies to interact.

 

For more information go to http://www.regonline.co.uk/tcells08

 

 

 

Confirmed Talks include:

Human Regulatory T cells- generation and maintenance Dr Milica Vukmanovic-Stejic, UCL, UK
Targeting regulatory T cells in patients with rheumatoid arthritis Professor Michael Ehrenstein, University College London, UK

The role of regulatory T cells in acute Dengue infection Dr Kerstin Luhn, University of Oxford, UK

How Treg suppression is overcome during onset of spontaneous diabetes? Dr Lucy Walker, Institute of Biomedical Research, University of Birmingham, UK
Interactions between CD4+CD25+ regulatory T cells and monocytes/macrophages: implications for the immune response Dr Leonie Taams, King's College London, UK

FOXP3+ regulatory T cells as biomarkers in human malignancies Dr Alison H. Banham, University of Oxford, UK

Comparing the phenotype and function of CD4 versus CD8 regulatory T cells Dr Alistair Noble, King's College London, UK

IL-10 and regulatory T cells in allergy and asthma Dr Catherine Hawrylowicz, King's College London, UK

The Impact of Tregs on Immune Responses to Tumours Dr Awen Gallimore, Cardiff University, UK

 

The deadline for early registration is January 10th 2008

Abstracts will be accepted for oral and poster presentations. All presentations will be published in the meeting proceedings.

 

We seek CPD accreditation from the IBMS for all our meetings

 

Analysing the Phenotype & Function of Regulatory T Cells: 7th March 2008